Sign Up to like & get
recommendations!
0
Published in 2022 at "ACS Applied Materials & Interfaces"
DOI: 10.1021/acsami.2c09641
Abstract: Using the biomarker hypermethylated DNA (hmDNA) for cancer detection requires a pretreatment to isolate or concentrate hmDNA from nonmethylated DNA. Affinity chromatography using a methyl binding domain-2 (MBD2) protein can be used, but the relatively…
read more here.
Keywords:
control mbd2;
hypermethylated dna;
receptor;
density control ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Oncogenesis"
DOI: 10.1038/s41389-021-00366-3
Abstract: Acute myeloid leukemia (AML) is a deadly cancer characterized by an expanded self-renewal capacity that is associated with the accumulation of immature myeloid cells. Emerging evidence shows that methyl-CpG-binding domain protein 2 (MBD2), a DNA…
read more here.
Keywords:
cell cycle;
loss mbd2;
mbd2;
mll af9 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Science Advances"
DOI: 10.1126/sciadv.aav9810
Abstract: The intrinsically disordered region of MBD2 is a promising target for treating cancer metastasis. Although intrinsically disordered protein regions (IDPRs) are commonly engaged in promiscuous protein-protein interactions (PPIs), using them as drug targets is challenging…
read more here.
Keywords:
rational discovery;
mbd2;
region mbd2;
intrinsically disordered ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer research"
DOI: 10.1158/0008-5472.can-17-1434
Abstract: Aberrant DNA methylation patterns in leukemia might be exploited for therapeutic targeting. In this study, we employed a genetically deficient mouse model to explore the role of the methylated DNA binding protein MBD2 in normal…
read more here.
Keywords:
wnt signaling;
mbd2 ablation;
mbd2;
progression maintenance ... See more keywords